Drug Trial Radar · NCT00958776
A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza
Last checked: Nov 20, 2026Latest source record: Feb 12, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
405
Actual
Start
Nov 2009
Primary completion
Nov 2012
Study completion Oct 2013
Sponsor
- Lead sponsor
- BioCryst PharmaceuticalsIndustry
- Sponsor type
- Industry
- Collaborators
- Department of Health and Human Services
- First posted
- Aug 13, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 3, multicenter, randomized, double-blind, controlled study to evaluate the efficacy and safety of peramivir administered intravenously in addition to standard of care compared to standard of care alone in adults and adolescents who are hospitalized due to serious influenza.
Conditions
- Cough
- Sore Throat
- Nasal Congestion
- Headache
- Fever
- Seasonal Influenza
Interventions
Peramivir+SOCDrug
* Adults (≥ 18 years): Peramivir (BCX-1812) 600 mg, administered intravenously, once daily (every 24 hrs) for 5 days (5 doses) in addition to institution's standard of care. * Adolescents (12-17 years): Peramivir (BCX-1812) 10 mg/kg (not to exceed a maximum dose of 600 mg), administered intravenously, once daily (every 24 hrs) for 5 days (5 doses) in addition to institution's standard of care.
Placebo+SOCDrug
Placebo Peramivir (BCX1812) administered intravenously, once daily (every 24 hrs) for 5 days (5 doses) in addition to institution's standard of care.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Clinical Resolution (Kaplan-Meier Estimate)Time frame: 10 days
Locations
196 sites in 23 countries. Site status is shown where the registry gives one.
Site not named
La Mesa, California
Site not named
Long Beach, California
Site not named
Modesto, California
Site not named
Oceanside, California
Pulmonary Consultants PC Physicians Medical Group, Inc.
Orange, California
Site not named
Orange, California
UC Davis Medical Center
Sacramento, California
Sharp Chula Vista Medical Center
San Diego, California
Site not named
San Diego, California
Site not named
Denver, Colorado
Drogue Medical, LLC
Wheat Ridge, Colorado
Washington Hospital Center CAR
Washington D.C., District of Columbia
Site not named
Washington D.C., District of Columbia
Site not named
Fort Lauderdale, Florida
Site not named
Miami, Florida
Site not named
Orlando, Florida
Site not named
West Palm Beach, Florida
Florida Hospital
Winter Park, Florida
Site not named
Columbus, Georgia
DeKalb Medical Center
Decatur, Georgia
Site not named
Savannah, Georgia
Site not named
Honolulu, Hawaii
Medical Arts Associates, Ltd.
Moline, Illinois
Site not named
Springfield, Illinois
Site not named
South Bend, Indiana
Kentucky Lung Clinic
Hazard, Kentucky
Site not named
Natchitoches, Louisiana
Site not named
New Orleans, Louisiana
Site not named
Annapolis, Maryland
Site not named
Baltimore, Maryland
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Wayne State University - Hutzel Hospital
Detroit, Michigan
Wayne State University, Department of Emergency Medicine
Detroit, Michigan
Site not named
Detroit, Michigan
William Beaumont Hospital
Royal Oak, Michigan
William Beaumont Hospital
Troy, Michigan
Washington University School of Medicine
St Louis, Missouri
Site not named
St Louis, Missouri
Site not named
Las Vegas, Nevada
Site not named
New Brunswick, New Jersey
Showing 40 of 196 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.